Amid mon­key­pox fears, biotechs spring to ac­tion; Mod­er­na’s CFO trou­ble; Cuts, cuts every­where; Craft­ing the right pro­teins; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

It’s al­ways a bit­ter­sweet mo­ment say­ing good­bye, but as Josh Sul­li­van goes off to new ad­ven­tures we are grate­ful for the way he’s built up the End­points Man­u­fac­tur­ing sec­tion — which the rest of the team will now car­ry for­ward. If you’re not al­ready, this may be a good time to sign up for your week­ly dose of drug man­u­fac­tur­ing news. Thank you for read­ing and wish you a rest­ful week­end.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER